Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Blood|November 1, 1993
Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivoM S Topp, M Koenigsmann, A Mire-Sluis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapyM Mohr, E Hilgenfeld, T Fietz, et al.
Cancer Medicine|April 2, 2026
Lenalidomide Plus Dexamethasone as FIRST-Line Therapy in Transplant-Ineligible Patients With Multiple Myeloma: Final Results of the Prospective, Non-Interventional Study FIRST-NIS and Comparison With the FIRST Pivotal Phase III Clinical TrialH Nückel, T Behlendorf, H Schulz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-upA R Zander, C Schmoor, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2015
The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax)S-E Al-Batran, W Hozaeel, F K Tauchert, et al.
Bone Marrow Transplantation|December 24, 2013
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trialM Koenigsmann, J Casper, C Kahl, et al.
British Journal of Cancer|January 19, 2013
A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancerA Atmaca, S-E Al-Batran, D Werner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2004
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trialA R Zander, N Kröger, C Schmoor, et al.
Pageof 4